Skip to main content

Abiomed Inc(ABMD-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low252.01
Day High260.87
Open:254.48
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Download Premium PDFValueEngine

Latest News

More Stories
Abiomed to Host Investor Call on Heart Failure Opportunity With Impella 5.5 and Impella BTR Heart Pumps
Business Wire - Tue Jun 14, 3:30PM CDT
Business Wire
Tue Jun 14, 3:30PM CDT
Abiomed, Inc . (NASDAQ: ABMD) today announced that it will host an investor call on the heart failure opportunity with the Impella 5.5 and future Impella BTR heart pumps on June 24, 2022 from 2:30 p.m. – 3:30 p.m. ET. The event will include...
Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference
Business Wire - Tue May 31, 6:00AM CDT
Business Wire
Tue May 31, 6:00AM CDT
Abiomed, Inc . (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42 nd Annual...
SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes
Business Wire - Wed May 18, 7:03AM CDT
Business Wire
Wed May 18, 7:03AM CDT
Abiomed (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock...

Latest Articles

number cruncher
These 11 growing companies from the S&P 500 are becoming increasingly attractive
Big Tech drives S&P 500 to record high in coronavirus rally
number cruncher
Ten U.S. stocks with the financial flexibility to withstand a second downturn
number cruncher
Twelve quality U.S. health care stocks for market uncertainty
number cruncher
Ten solid, growth-oriented U.S. health-care stocks
Another medtech stock has quietly slipped into lead in S&P 500
Twenty U.S. stocks that mix price momentum and solid fundamentals
Twenty U.S. stocks for momentum investors
number cruncher
Twenty U.S. stocks with both earnings and price momentum
number cruncher
Best of both worlds: Looking for value and momentum stocks
Need help predicting M&A takeover targets?
Companies

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2022.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2022 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.